These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 35896699)
1. DJ-1 controls T cell differentiation and osteoclastogenesis in rheumatoid arthritis. Min HK; Kim SH; Lee JY; Lee SH; Kim HR Sci Rep; 2022 Jul; 12(1):12767. PubMed ID: 35896699 [TBL] [Abstract][Full Text] [Related]
2. IL-18 binding protein suppresses IL-17-induced osteoclastogenesis and rectifies type 17 helper T cell / regulatory T cell imbalance in rheumatoid arthritis. Min HK; Kim S; Lee JY; Kim KW; Lee SH; Kim HR J Transl Med; 2021 Sep; 19(1):392. PubMed ID: 34530864 [TBL] [Abstract][Full Text] [Related]
3. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis. Kim KW; Kim HR; Kim BM; Cho ML; Lee SH Am J Pathol; 2015 Nov; 185(11):3011-24. PubMed ID: 26362732 [TBL] [Abstract][Full Text] [Related]
4. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344 [TBL] [Abstract][Full Text] [Related]
5. Quercetin, a Plant Polyphenol, Has Potential for the Prevention of Bone Destruction in Rheumatoid Arthritis. Kim HR; Kim BM; Won JY; Lee KA; Ko HM; Kang YS; Lee SH; Kim KW J Med Food; 2019 Feb; 22(2):152-161. PubMed ID: 30596535 [TBL] [Abstract][Full Text] [Related]
6. N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL production in rheumatoid arthritis. Kim HR; Kim KW; Kim BM; Lee KA; Lee SH Korean J Intern Med; 2019 Jan; 34(1):210-219. PubMed ID: 28286938 [TBL] [Abstract][Full Text] [Related]
7. Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis. Lee KA; Kim KW; Kim BM; Won JY; Min HK; Lee DW; Kim HR; Lee SH Arthritis Res Ther; 2019 Dec; 21(1):283. PubMed ID: 31831038 [TBL] [Abstract][Full Text] [Related]
8. IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis. Moon YM; Yoon BY; Her YM; Oh HJ; Lee JS; Kim KW; Lee SY; Woo YJ; Park KS; Park SH; Kim HY; Cho ML Arthritis Res Ther; 2012 Nov; 14(6):R246. PubMed ID: 23148681 [TBL] [Abstract][Full Text] [Related]
9. Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway. Min HK; Won JY; Kim BM; Lee KA; Lee SJ; Lee SH; Kim HR; Kim KW Arthritis Res Ther; 2020 Sep; 22(1):222. PubMed ID: 32972460 [TBL] [Abstract][Full Text] [Related]
10. Tocotrienol regulates osteoclastogenesis in rheumatoid arthritis. Kim KW; Kim BM; Won JY; Min HK; Lee SJ; Lee SH; Kim HR Korean J Intern Med; 2021 Mar; 36(Suppl 1):S273-S282. PubMed ID: 32550719 [TBL] [Abstract][Full Text] [Related]
11. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6. Dickerson TJ; Suzuki E; Stanecki C; Shin HS; Qui H; Adamopoulos IE J Autoimmun; 2012 Dec; 39(4):369-76. PubMed ID: 22867712 [TBL] [Abstract][Full Text] [Related]
12. Reciprocal activation of CD4+ T cells and synovial fibroblasts by stromal cell-derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis. Kim HR; Kim KW; Kim BM; Jung HG; Cho ML; Lee SH Arthritis Rheumatol; 2014 Mar; 66(3):538-48. PubMed ID: 24574213 [TBL] [Abstract][Full Text] [Related]
13. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways. Li X; Kim KW; Cho ML; Ju JH; Kang CM; Oh HJ; Min JK; Lee SH; Park SH; Kim HY Immunol Lett; 2010 Jan; 127(2):100-7. PubMed ID: 19900478 [TBL] [Abstract][Full Text] [Related]
14. Effects of IL-34 on the secretion of RANKL/OPG by fibroblast-like synoviocytes and peripheral blood mononuclear cells in rheumatoid arthritis. Cui MY; Li X; Lei YM; Xia LP; Lu J; Shen H Eur Cytokine Netw; 2019 Jun; 30(2):67-73. PubMed ID: 31486401 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-33 acts as a transcriptional repressor and extracellular cytokine in fibroblast-like synoviocytes in patients with rheumatoid arthritis. Lee EJ; So MW; Hong S; Kim YG; Yoo B; Lee CK Cytokine; 2016 Jan; 77():35-43. PubMed ID: 26520876 [TBL] [Abstract][Full Text] [Related]
16. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand. Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184 [TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of rheumatoid synoviocytes to Schnurri-3 expression in TNF-α and IL-17A induced osteoblastic differentiation. Lavocat F; Osta B; Miossec P Bone; 2016 Jun; 87():89-96. PubMed ID: 27072520 [TBL] [Abstract][Full Text] [Related]
18. RANKL expression in chondrocytes and its promotion by lymphotoxin-α in the course of cartilage destruction during rheumatoid arthritis. Takeshita A; Nishida K; Yoshida A; Nasu Y; Nakahara R; Kaneda D; Ohashi H; Ozaki T PLoS One; 2021; 16(7):e0254268. PubMed ID: 34234380 [TBL] [Abstract][Full Text] [Related]
19. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Kim KW; Cho ML; Lee SH; Oh HJ; Kang CM; Ju JH; Min SY; Cho YG; Park SH; Kim HY Immunol Lett; 2007 May; 110(1):54-64. PubMed ID: 17467812 [TBL] [Abstract][Full Text] [Related]
20. The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis. Kim HR; Kim KW; Kim BM; Cho ML; Lee SH PLoS One; 2015; 10(4):e0124909. PubMed ID: 25894998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]